Es gibt sogar ein Ranking des Medizintourismus.
Zitat aus
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Beirut’s Clemenceau in world’s top 10 for medical tourismBeirut-based Clemenceau Medical Center (CMC), an affiliate of Johns Hopkins International, was ranked one of the world’s top ten best hospitals for medical tourism in 2010 by the Medical Travel Quality Alliance (MTQUA). CMC was the only healthcare facility in the Arab world and Middle East region that made the list.
The MTQUA assessment was based on strict criteria including patient safety and security, medical quality and outcomes and international patient management.
CMC has continued to promote medical tourism in Lebanon and the Middle East through its participation in key international medical tourism conferences in Dubai, Singapore, Malaysia, the United States and other countries.
The hospital’s JCI accreditation in 2009 has also contributed to enhancing its position on the medical tourism world map.
“While CMC took part in medical tourism conferences, the establishment of an International Patient Services Department at CMC was essential to manage and facilitate the provision of services to international patients,” said Dr Mounes Kalaawi, Chief Executive Officer of CMC hospital. “With that service at hand, we were able to manage 4,000 International patients in 2009.”
[*/quote*]
Weitere Themen der gleichen Seite:
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Opening of Cairo office a high point for ClinTecClinTec International, a leading contract research organisation (CRO), which has achieved 45% growth in global sales revenues over the past year, says the opening of an office in Cairo in October last year was one of the highlights of the year.
The company has a presence in 40 countries worldwide. ClinTec manages clinical trials in all major therapeutic areas, including oncology, neurology, gastroenterology, as well as cardiovascular, respiratory medicine. Dr Rabinder Buttar, the company’s founder, President and CEO, said: “The launch of our Cairo office in October was one of the high points of the year.
Apart from providing our global pharmaceutical associates with access to new patient populations, ClinTec Cairo cements our reputation as the major CRO in the Middle East and North Africa region. “ClinTec International excels at opening up new and emerging markets. Our unrivalled knowledge of different regulatory requirements and cultures is our strength.”
[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
China-based Neusoft opens office in DubaiChina-based Neusoft Medical Systems has opened an office in Dubai to headquarter its Middle East subsidiary.
Neusoft is a market leader in the provision of imaging equipment and medical IT solutions in China and has more than 5,000 customers in more than 60 countries and regions around the world.
Its products include CT, MRI, X-ray, ultrasound and a range of medical IT packages including miniPACS, mammoCAD and OsteoCARE. The company says that the opening of the Dubai office is a major milestone in its global expansion and will enable it to establish a stronger foothold in the Middle East where it already has a number of customers.
“The subsidiary will provide a wide range of high-quality medical products and timely services to local customers, and enhance the company’s competitiveness in this market,” the company said in a statement.
[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Cosmetic surgery hospital at DHCC gets JCI accreditation
The
American Academy of Cosmetic Surgery Hospital (AACSH) located at Dubai Healthcare City has been granted the prestigious Joint Commission International (JCI) accreditation.
Dr Jeehan Abdul Qader, Executive Director of AACSH, said: “The JCI accreditation that confirms our commitment to the highest standards of medical services. Our wide portfolio of reconstructive surgeries and elective lifestyle cosmetic surgeries continues to ensure a steady stream of overseas patients.”
AACSH offers expertise in pre and post-surgical psychotherapy, nutrition, cosmetic dentistry and has a maxillofacial unit, as well as a beauty club for pre and post surgical rehabilitation. Other facilities at AACSH include five fully-equipped modern operating theatres, post surgical private recovery rooms with deluxe presidential and royal suites.
[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
DHA and GSK set up asthma management initiative
The Dubai Health Authority (DHA) and drug company GlaxoSmithKline (GSK) have signed an MoU to set up the Asthma Management Partnership Initiative.
The joint initiative will seek to establish Dubai as a centre for excellence in respiratory care. The partnership follows a recent study sponsored by GSK, which showed the UAE to have one of the highest rates of asthma, with rates of diagnosis as high as 13%.
The initiative aims to improve effective asthma diagnosis, care and manage ment with the training and support of respiratory nurse specialists. Management guidelines will follow the Global Initiative for Asthma (GINA)
http://www.ginasthma.comThe project will also seek to reinforce asthma management plans to ensure patient compliance and benchmark the indictors of asthma care to allow continuous improvement. The project will rely on the partnership between doctors and respiratory nurse specialists in order to provide a multidisciplinary approach to the management of asthma.
Dr Bassam Mahboub, head of the Pulmonology Department at the DHA and project leader of the Asthma Management Partnership Initiative, commented: “Poor asthma management is a major cost to any economy and its healthcare system, not to mention a danger to life and lifestyle.
Therefore we believe that educating and training our primary healthcare practitioners like our nurses will lead to substantial improvement in asthma management.
Introducing specialist asthma teams across our polyclinics will most certainly help diagnose asthma at an early stage and provide effective treatment for our patients.”
[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
40 Gulf specialists to get grants for advanced diabetes course
The drug company Sanofiaventus will provide complimentary educational grants to 40 Gulf specialists to undertake an advanced course in diabetes.
The Post Graduate Diabetes Diploma offered by Cardiff University in the UK is a twoyear part-time, distance learning course. The course is organised and led by the Diabetes Research Unit at the School of Medicine, Cardiff University, with the leadership of Professor David R Owens, Professor of Diabetes Medicine, Cardiff University.Prof Owens is also the Director of the Diabetes Research Unit at Llandough Hospital in Cardiff, and has been involved in diabetes research for more than 30 years. The initiative is a joint collaboration between Sanofiaventis pharmaceuticals and the Emirates Diabetes Society (EDS), Kuwait Diabetes Society (KDS) and Qatar Diabetes Association (QDA) as well as various health authorities in the UAE.
The aim of the programme is to provide advanced diabetes education for doctors specialising in diabetes. Throughout the course, considerable emphasis will be placed upon patho-physiology and the clinical management of diabetes.
Dr Abdullah Ben Nakhi, Consultant Diabetologist, and head of KDS, commented: “The reason this initiative is crucial for improving diabetes rates in this region is because it directly targets healthcare professionals who are the key influencers in the fate of this disease. Usually the top diabetes specialists in the region are the ones that set the standard in diabetes treatment.
Once these handful of specialists are all following the same principle guidelines taught in this course, then a norm will be set within the healthcare system; a norm that has been applied, tested and proven to be extremely successful in foreign healthcare structures.”
[*/quote*]
Professor Dr. Karl Aigner ist mit dabei:
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Regional chemo pioneer consults at Dubai’s IMH
The International Modern Hospital (IMH) in Dubai announced that it will have one of the world’s leading oncologists consulting at the hospital.
Professor Dr Karl Reinhard Aigner, head of oncologic surgery at the Medias Klinikum in Burghausen, Germany and one of the pioneers of ‘regional chemotherapy’ (RCT), will be available for consultation and the provision of treatment at IMH.
He will practice with his team of specialised physicians. Regional chemotherapy is used in the treatment of solid tumours. It has fewer side effects compared to conventional chemotherapy.
In regional chemotherapy, medication is injected into the site of the tumour, specifically an artery serving the tumour or tumour region. This targeted approach to treatment allows a considerably higher chemotherapy dose to be administered which results in more rapid and effective treatment.
Prof Aigner explained: “Most of the patients who come to us are those who have not responded well to chemotherapy or those who have had a relapse.
Various medical studies have published results pointing to convincing data in terms of tumour response, quality of life and survival of those treated with RCT. For instance, it has been well established that pancreatic cancer, a killer cancer, responds well to RCT when other chemotherapies have failed.
Breast cancer too has been treated with almost no side effects and without amputation. The response rate of breast cancer has been 80% to 95% with RCT.
“Additionally, even advanced cancers of the bladder and the prostate are treated by means of the isolated pelvic perfusion technique with chemofiltration, avoiding mutilating surgery, impotence and incontinence.”[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Dubai to host World Hospital Congress
Next year Dubai will host the International Hospital’s Federation’s 37th World Hospital Congress.The congress serves as a platform for health professionals share knowledge about hospital administration and various aspects of medical science.
Dubai will be the first city in the Arab world to do so. The biennial event, which will take place in the city from 29-31 March, 2011, moves its location for each event.
The theme of IHF 37th World Hospital Congress is: “Shifting Paradigms: Anticipating the Ethical Challenges of New Health Technologies and Procedures in a Globalizing World - Developing Ethics in Hospitals and Health Services.”
Dr Jose Carlos De Souza Abrahao, President, International Hospital Federation, says: “IHF 2011 is a unique opportunity to know more about the Middle East Hospital industry.
It will provide the chance to exchange ideas and viewpoints with our peers from around the world. I hope this conference helps further our efforts to apply the best practices in our field and share them with our colleagues.”
● For more information visit:
http://www.ihfdubai.ae[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Johns Hopkins, Saudi eye hospital in joint initiative
The Wilmer Eye Institute of Johns Hopkins Medicine in Baltimore, USA, has set up a collaborative initiative with King Khaled Eye Specialist Hospital (KKESH) in Riyadh, Saudi Arabia, which will cover research, education (a key focus of the initiative) and patient care.
KKESH is the largest eye hospital in Saudi Arabia. Dr Peter J. McDonnell, William Holland Wilmer Professor of Ophthalmology and the director of the Wilmer Institute, said: “We at the Wilmer Institute have long been interested in the study and cure of blinding eye diseases around the world, and the King Khaled Eye Specialist Hospital is certainly one of the most impressive eye hospitals outside of the United States.”
He added that he hoped the collaboration would see a more rapid evaluation of potential new therapies than would be possible with either hospital working alone.
According to a statement several Wilmer faculty members will work at the hospital for extended periods – treating patients, teaching and conducting research.
With financial support from the Saudi Government, joint research activities will focus on developing treatments for blinding eye diseases. A new endowed professorship at Johns Hopkins will be established to support the work of Hopkins’ faculty.
[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Kuwait hospitals, Johns Hopkins to cooperateKuwait’s Al Farwaniya, Amiri, Addan and Jahra hospitals have established cooperation agreements with John Hopkins University and Hospital, according to Dr Hilal Al-Sayer, Kuwait’s minister of health.
The initiative will look at ways to provide training, technical support, information systems, laboratories, radiology, and improve the quality of services at the hospitals.
[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Medical tourism company links Belgium, GCCMediaway, the medical bridge between Belgium and the Arab World, has teamed up with The Rocco Forte Collection’s Hotel Amigo in Brussels, along with select partners Etihad Airways, The Edith Cavell Hospital, Dockx Car Rental and Visit Belgium, to offer a new medical package to residents of the Gulf countries.
Belgium has emerged as one of Europe’s leading medical tourism destinations, offering medical tourists a highly-regarded level of medical care and research across all medicinal disciplines.
The new medical package, which is directly linked to the respected Edith Cavell Hospital, is tailormade to the influx of Arab nationals seeking treatment in Belgium’s medical facilities and offers travellers a comprehensive package, complete with medical staff that are fluent in Arabic.
● For further information or to make a booking, call (UAE) 8000 650592 or visit
http://www.roccofortecollection.com[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
New CEO appointed for Tawam in Al Ain
Johns Hopkins Medicine International (JHI), the international arm of United Statesbased Johns Hopkins Medicine, and the Abu Dhabi Health Services Company (SEHA) have appointed Gregory F. Schaffer to be the new chief executive officer of Tawam Hospital in Al Ain, UAE.Schaffer has more than 30 of years of health care leadership experience and is a Fellow of the American College of Healthcare Executives (FACHE). He served as president and chief executive officer of Johns Hopkins Bayview Medical Center, Baltimore, Maryland, US, for 10 years.
Commenting on his appointment, Schaffer said: “I have known the Johns Hopkins brand and philosophy for many years. It is a wonderful opportunity to be able to enjoy a new cultural experience and bring Hopkins expertise and knowledge to the emirates.
Tawam has a well-deserved reputation for being one of the region’s leaders in healthcare delivery. We will do our best to help Tawam maintain and expand its important role." Tawam Hospital in affiliation with John Hopkins Medicine is a premier, 477-bed tertiary care facility.
The hospital serves as a regional referral centre for specialised medical care and a national referral centre for oncology services.
[*/quote*]
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Philips, DHA to set up CME academyThe Dubai Health Authority and Philips have announced a joint venture to develop Continuous Medical Education (CME) academy of excellence in Dubai.
The academy will offer international and local accredited courses for medical practitioners in the UAE and GCC countries. The academy is expected to open within six months. The joint venture will be managed and funded by Active-M, a venture capital company.
Louis Hakim, VP of Royal Philips Electronics and CEO of Philips Middle East said that the company will leverage its world-wide network with academic bodies for the benefit of the joint venture.
“Philips will also provide curriculum for topics that need regional development, in line with topics identified by the DHA clinical expertise,” he said.
[*/quote*]
Zitate aus dem MiddleEastMag sind
http://www.middleeasthealthmag.com/mar2010/meupdate.htmCopyright © 2010 MiddleEastHealthMag.com. All Rights Reserved.
Es sind Beweisstücke für eine starke Verflechtung der Reichen in den Ölländern wie Dubai mit der Medizinszene in Europa, Asien und den Amerikas.
Die Araber wissen nicht, was im Rest der Welt passiert. Sie können sich nur ihrer Boten, Medien und Lobbyisten bedienen, und die fragen, was zum Beispiel in Deutschland medizinisch läuft. Im MiddleEastMag gibt es die bereits zitierte Meldung:
http://www.middleeasthealthmag.com/mar2010/meupdate.htm[*quote*]
Regional chemo pioneer consults at Dubai’s IMH
The International Modern Hospital (IMH) in Dubai announced that it will have one of the world’s leading oncologists consulting at the hospital.
Professor Dr Karl Reinhard Aigner, head of oncologic surgery at the Medias Klinikum in Burghausen, Germany and one of the pioneers of ‘regional chemotherapy’ (RCT), will be available for consultation and the provision of treatment at IMH.
He will practice with his team of specialised physicians. Regional chemotherapy is used in the treatment of solid tumours. It has fewer side effects compared to conventional chemotherapy.
In regional chemotherapy, medication is injected into the site of the tumour, specifically an artery serving the tumour or tumour region. This targeted approach to treatment allows a considerably higher chemotherapy dose to be administered which results in more rapid and effective treatment.
Prof Aigner explained: “Most of the patients who come to us are those who have not responded well to chemotherapy or those who have had a relapse.
Various medical studies have published results pointing to convincing data in terms of tumour response, quality of life and survival of those treated with RCT. For instance, it has been well established that pancreatic cancer, a killer cancer, responds well to RCT when other chemotherapies have failed.
Breast cancer too has been treated with almost no side effects and without amputation. The response rate of breast cancer has been 80% to 95% with RCT.“Additionally, even advanced cancers of the bladder and the prostate are treated by means of the isolated pelvic perfusion technique with chemofiltration, avoiding mutilating surgery, impotence and incontinence.”
[*/quote*]
Studien haben gezeigt? Welche? Was ist mit den Erfolgsraten? Wo sind die reproduzierbar nachgewiesen worden?
Krebskranke mit einer Überlebenschance von null, weil sie von der herkömmlichen Medizin als nicht mehr sinnvoll therapierbar aufgegeben wurden, interessiert das nicht. Auch die noch so kritischen Bewohner Altöttings und Umgebung, die das Kommen und Gehen der Patienten miterleben, würden, wenn sowieso alles im Eimer ist, TROTZDEM alles probieren, und sei es noch so hirnrissig. Zu verlieren haben sie ja nichts mehr.
Das ist das Futter der Medizinindustrie. Über Verteilzentren und Logistik holt sie ihre Beute. Man nennt es Medizintourismus.
Menschen als Verbrauchsmaterial ist die passendere Bezeichnung.